Biomarkers · Anthropometric
Waist-to-Height Ratio (WHtR)
Lower values go with lower risk of death. In NHANES 1999–2018 with linked mortality to 2019, each standard deviation above average goes with 9% higher risk of death. We found the same pattern in NHANES
WHtR and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to each curve's own reference value, so the two curves need not cross 1 at the same point. The dotted vertical line marks the NHANES median.
WHtR across cohorts
* Measured differently from NHANES (see the note on the row); compare direction more than size.
WHtR by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 0.43 | 0.49 | 0.56 | 0.64 | 0.77 | 1,465 | NHANES 2017-2018 |
| All | 40-59 | 0.47 | 0.54 | 0.59 | 0.66 | 0.80 | 1,577 | NHANES 2017-2018 |
| All | 60+ | 0.49 | 0.57 | 0.62 | 0.68 | 0.78 | 1,845 | NHANES 2017-2018 |
| All | all | 0.45 | 0.53 | 0.59 | 0.66 | 0.79 | 4,887 | NHANES 2017-2018 |
| Men | 20-39 | 0.42 | 0.49 | 0.55 | 0.62 | 0.72 | 709 | NHANES 2017-2018 |
| Men | 40-59 | 0.47 | 0.55 | 0.59 | 0.65 | 0.77 | 745 | NHANES 2017-2018 |
| Men | 60+ | 0.49 | 0.56 | 0.62 | 0.67 | 0.75 | 950 | NHANES 2017-2018 |
| Men | all | 0.44 | 0.53 | 0.59 | 0.65 | 0.75 | 2,404 | NHANES 2017-2018 |
| Women | 20-39 | 0.43 | 0.49 | 0.56 | 0.67 | 0.81 | 756 | NHANES 2017-2018 |
| Women | 40-59 | 0.45 | 0.52 | 0.60 | 0.69 | 0.82 | 832 | NHANES 2017-2018 |
| Women | 60+ | 0.49 | 0.57 | 0.63 | 0.69 | 0.80 | 895 | NHANES 2017-2018 |
| Women | all | 0.45 | 0.53 | 0.60 | 0.68 | 0.81 | 2,483 | NHANES 2017-2018 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in WHtR, study by study
1 effect with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| pharmacologic | Subcutaneous semaglutide 2.4 mg once weekly for up to 4 years in adults with overweight/obesity and cardiovascular disease without diabetes | Waist-to-height ratio -6.9% with semaglutide vs -1.0% with placebo at 208 weeks | RCT | Ryan DH, Lingvay I, Deanfield J, et al. Nat Med. 2024. |
Sources
- Risk curve: Abdi Dezfouli R 2023 (PMID 37770574): all-cause HR 1.16 (1.07-1.25) continuous WHtR, per 1 SD increment. Scaled to US values (NHANES).
- Abdi Dezfouli R, Mohammadian Khonsari N, Hosseinpour A, Sheidaei A, Baygi F, Djalalinia S, et al. Waist to height ratio as a simple tool for predicting mortality: a systematic review and meta-analysis. Int J Obes (Lond). 2023;47(12):1286-1293.
- NHANES curve: our Cox model adjusted for age and sex, NHANES 1999–2018 with linked mortality to 2019.
Map Waist-to-Height Ratio (WHtR) against another biomarker.
Related markers: Appendicular Lean Mass / Sarcopenia Index · Basal Metabolic Rate · Body Fat Percentage · Body Mass Index (BMI) · Body Weight · Calf Circumference · Fat Mass · Fat-Free Mass